Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
VOL 4 No. 2 Full Issue - February 2002
1
x
$
20.00
El libro negro de dosificación y monitoreo de sustancias psicotrópicas
1
x
$
30.00
Jamie D. Feusner - Differential Efficacy of Memantine for Obsessive-Compulsive Disorder vs.Generalized Anxiety Disorder: An Open-Label Trial
1
x
$
30.00
A Failed 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of Once-Daily Extended Release Quetiapine Fumarate in Patients with Acute Schizophrenia: Lessons Learned
1
x
$
30.00
View Cart
Checkout
Home
psychopharmacology-bulletin
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Boadie W. Dunlop, MD: Disturbed Glucose Metabolism Among Patients Taking Olanzapine and Typical Antipsychotics
$
30.00
Add to cart
Details
Patricia K. Corey-Lisle, PhD, RN,CS-P: Economic Impact of Olanzapine Plus Fluoxetine Combination Therapy Among Patients Treated for Depression: A Pilot Study
$
30.00
Add to cart
Details
Igor Elman, MD: Acute Cortisol Administration Triggers Craving in Individuals with Cocaine Dependence
$
30.00
Add to cart
Details
Andrea de Bartolomeis, MD, PhD: The Homer Family and the Signal Transduction System at Glutamatergic Postsynaptic Density: Potential Role in Behavior and Pharmacotherapy
$
30.00
Add to cart
Details
Gregory M. Asnis, MD: IFN-Induced Depression: A Role for NSAIDs
$
30.00
Add to cart
Details
Ranga Krishnan, MB, ChB: Evidence-Based Decision-Making in Psychopharmacology
$
30.00
Add to cart
Details
Douglas G. Kondo, MD: An Evidence-Based Medicine Approach to Combined Treatment for ADHD in Children and Adolescents
$
30.00
Add to cart
Details
Charles B. Nemeroff, MD, PhD: The Role of GABA in the Pathophysiology and Treatment of Anxiety Disorders
$
30.00
Add to cart
Details
C. Lindsay DeVane, PharmD: Risperidone in the Management of Psychiatric and Neurodegenerative Disease in the Elderly: An Update
$
30.00
Add to cart
Details
Alexander Neumeister, MD: Tryptophan Depletion, Serotonin, and Depression: Where Do We Stand?
$
30.00
Add to cart
Details
K. Ranga Rama Krishnan, MB, ChB: Evidence-Based Practice: How to Evaluate What You Read
$
30.00
Add to cart
Details
James H. Kocsis, MD: Continuation Treatment of Chronic Depression: A Comparison of Nefazodone, Cognitive Behavioral Analysis System of Psychotherapy, and Their Combination
$
30.00
Add to cart
Details
Gwenn S. Smith, PhD: Applications of Neuroreceptor Imaging to Psychiatry Research
$
30.00
Add to cart
Details
Mikael Landén, MD, PhD: A Model to Explain the Therapeutic Effects of Serotonin Reuptake Inhibitors: The Role of 5-HT2 Receptors
$
30.00
Add to cart
Details
George Harrison, MD: Priapism and Quetiapine: A Case Report
$
30.00
Add to cart
Details
Jose M. Canive, MD: Efficacy of Olanzapine and Risperidone in Schizophrenia: A Randomized Double-Blind Crossover Design
$
30.00
Add to cart
Details
Mark Zetin, MD: Rational Antidepressant Selection: Applying Evidence-Based Medicine to Complex Real-World Patients
$
30.00
Add to cart
Details
Arif Khan, MD: Suicide Risk Analysis Among Patients Assigned to Psychotropics and Placebo
$
30.00
Add to cart
Details
David V. Sheehan, MD, MBA: Current Approaches to the Pharmacologic Treatment of Anxiety Disorders
$
30.00
Add to cart
Details
Aysegul Yolga Tahiroglu, MD: Polypharmacy and EPS in a Child; A Case Report
$
30.00
Add to cart
Details
Previous
1
…
5
6
7
…
10
Next
Page load link
Go to Top
